Broadwood Partners, L.P., 10% Owner at OncoCyte Corp (OCX), bought 2,000,000 shares at $1.66 ($3.3M) on 2019-09-11, disclosed to the SEC on 2019-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| STAA | BUY | 2026-03-13 | $12.3M | — | Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-04-07 | $27.2M | — | Filing → |